CorMedix CRMD
NASDAQ CRMD
$7.85 -0.25 (-3.09%)
At close: Oct 23, 2026 · 4:00 PM EDT

CorMedix (CRMD) Amortization of Deferred Charges (2012 - 2019)

Updated

Analysis

CorMedix (CRMD) Amortization of Deferred Charges (2012 - 2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 CorMedix 609.69 Mn -42.83 Mn 77.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 84,000.00
Jun 30, 2019 114,547.00
Mar 31, 2019 114,548.00
Mar 31, 2013 328,761.00
Dec 31, 2012 259,846.00
API Access

CorMedix Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=CRMD&period=max&api_key=YOUR_API_KEY